Omega Research Group

Orlando, Florida 32810

1 studies enrolling now · 3 studies all time

What they study most

Hepatic Impairment, SLE, SLE (Systemic Lupus), Sickle Cell Disease

Studies at this site

• A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus — Recruiting now
• Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease — Stopped early
• KD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment — Completed